Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX) Vaccine for Leukemia...

Dr. Don Diamond has stated, "The City of Hope is excited to license this vaccine to GeoVax (GOVX) to progress to large-scale...

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

New report nearly doubles the GeoVax addressable market of Immunocompromised Patients (i.e. potential customers) from 15 Million, to 23 Million patients! Not...

Killer, 44-Page Report on GeoVax (GOVX).

And a Nine-Page Summary Report..Great Weekend Reading. This is one killer report. In fact if we might be so...

Adding Terran Orbital (LLAP) $1.15 to Watch List. Risk Arbitrage Idea.

Lockheed Martin (LMT) Offers $1.00 Per Share to Acquire Terran Orbital. LIVE QUOTE

Amylyx (AMLX) Go Kaboom!

The Above Chart Looks Nice..Goldman Sachs (see below) had $46 Price Target. Market Capitalization at 9:20 $1.29 billion -...

GeoVax Live Webcast

Tonight, Monday at 5:30 PM. And You Don't Fly to Newport Beach and Deal With all the Drinking, Investment Bankers, and...

IMAC Holdings (BACK) Explodes 94% Higher Post Reverse Split, With 42 Million Shares Trading...

Simply Incredible! 2024 Will be the Year of Post Reverse Split Revenge! Taking advantage of post reverse-split investor...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

GeoVax to Present at World Vaccine Congress, Thursday April 4th.

Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-CM04S1, the Company’s next-generation non-MRNA Covid-19 vaccine...

Latest article

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...